Skip to main content
Complete Olympic Games coverage at your fingertips
Your inside track on the Olympic Games
Enjoy unlimited digital access
per week for 24 weeks
Complete Olympic Games coverage at your fingertips
Your inside track onthe Olympics Games
per week
for 24 weeks
// //

Johnson & Johnson NYSE: JNJ-N

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Today's Trading

Day Low 171.87
Day High 171.87
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

More stories below advertisement

Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin care, oral care, wound care, and women's health fields, nutritional and over-the-counter pharmaceutical products. The company's Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, thrombosis, vaccines, and infectious diseases. Its Medical Devices and Diagnostics segment offers electrophysiology and circulatory disease management products; orthopaedic joint reconstruction, spinal care, neurological, and sports medicine products; surgical care, aesthetics, and women's health products. Johnson & Johnson is based in New Brunswick, New Jersey.


Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio


Corporate earnings are provided from Zacks Investment Research, including Income Statements, Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research.

Moderate Buy


What is this stock worth in intrinsic value? View this premium StockCalc report to see this stock's valuation and how it was calculated using fundamental analysis. For subscribers only.


A stock valuation and forecasting report include rating, fair value assessment, return forecasts, market ratio-based valuations and comparable analysis. Available for free with registration.

Latest Press Releases

Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Johnson & Johnson (NYSE:JNJ) Investigation
- ACCESSWIRE - Fri Jul 23, 10:00AM CDT
Fri Jul 23, 10:00AM CDT
NEW YORK, NY / ACCESSWIRE / July 23, 2021 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Johnson & Johnson ('J&J" or 'the Company') (NYSE:JNJ). Investors who purchased J&J shares are encouraged to obtain additional information and assist the investigation by visiting the firm's site: .
Delta Variant Infections of COVID Rising Quickly & Now Responsible for 83% of All U.S. Cases
- PR Newswire - PRF - Thu Jul 22, 8:30AM CDT
PR Newswire - PRF - CMTX
Thu Jul 22, 8:30AM CDT
PALM BEACH, Fla., /PRNewswire/ -- According to WebMD, this week the nation's top health officials  Tuesday that the Delta variant of the coronavirus is racing through and other parts of the world and now is responsible for 83% of all U.S. cases alone. That's a massive increase from a week ago, when Delta was seen as responsible for just more than half of new cases, CDC Director , MD, told a Senate committee. "The best way to prevent the spread of COVID-19 variants is to prevent the spread of disease, and vaccination is the most powerful tool we have," she said. Meanwhile, several states in the South are reporting a large increase in COVID-19 cases, particularly in areas with low vaccination rates, according , , and are reporting full-fledged outbreaks, and neighboring states such as , , , , , and are following behind.  to the National Institutes of Health (NIH): "When variants of SARS-CoV-2 (the virus that causes COVID-19) emerged in late 2020, concern arose that they might elude protective immune responses generated by prior infection or vaccination, potentially making re-infection more likely or vaccination less effective. To investigate this possibility, researchers from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and colleagues analyzed blood cell samples from 30 people who had contracted and recovered from COVID-19 prior to the emergence of virus variants. They found that one key player in the immune response to SARS-CoV-2—the CD8+ T cell—remained active against the virus."  Active biotech companies in the market this week include (OTCQB: BVAXF) (CSE: BIOV), . (NYSE: PFE), (NYSE: JNJ), (NASDAQ: MRNA), (NASDAQ: SRNE).
Delta Means Beta Testing Alpha Strategies in Biotech (NVAX, MRNA, DYAI, PFE, JNJ, BNTX, AZN, IBB)
- WallStreetPR - Thu Jul 22, 7:07AM CDT
WallStreetPR - CMTX
Thu Jul 22, 7:07AM CDT
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 163.41 +5.18% increase
on 06/29/21
Period Open:164.21
Price movement based on the high, low and last over the given period.
172.18 -0.18% decrease
on 07/23/21
+7.66 (+4.66%) increase
since 06/25/21
3-Month 161.65 +6.32% increase
on 04/28/21
Period Open:163.18
Price movement based on the high, low and last over the given period.
172.74 -0.50% decrease
on 05/21/21
+8.69 (+5.33%) increase
since 04/27/21
52-Week 133.65 +28.60% increase
on 10/30/20
Period Open:147.18
Price movement based on the high, low and last over the given period.
173.65 -1.03% decrease
on 01/26/21
+24.69 (+16.78%) increase
since 07/27/20

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2021.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

© 2021 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies